PL2730562T3 - Sposób syntezy (2E)-3-(3,4-dimetoksyfenylo)prop-2-enonitrylu i jego zastosowanie w syntezie iwabradyny i jej soli addycyjnych z dopuszczalnym farmaceutycznie kwasem - Google Patents

Sposób syntezy (2E)-3-(3,4-dimetoksyfenylo)prop-2-enonitrylu i jego zastosowanie w syntezie iwabradyny i jej soli addycyjnych z dopuszczalnym farmaceutycznie kwasem

Info

Publication number
PL2730562T3
PL2730562T3 PL13191850T PL13191850T PL2730562T3 PL 2730562 T3 PL2730562 T3 PL 2730562T3 PL 13191850 T PL13191850 T PL 13191850T PL 13191850 T PL13191850 T PL 13191850T PL 2730562 T3 PL2730562 T3 PL 2730562T3
Authority
PL
Poland
Prior art keywords
synthesising
enenitrile
dimethoxyphenyl
prop
pharmaceutically acceptable
Prior art date
Application number
PL13191850T
Other languages
English (en)
Inventor
Maria Del Pilar Carranza
Aranda Maria Isabel Garcia
José Lorenzo Gonzalez
Frédéric Sanchez
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of PL2730562T3 publication Critical patent/PL2730562T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00—Preparation of carboxylic acid nitriles
    • C07C253/32—Separation; Purification; Stabilisation; Use of additives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00—Preparation of carboxylic acid nitriles
    • C07C253/30—Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J23/00—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
    • B01J23/38—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals
    • B01J23/40—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals of the platinum group metals
    • B01J23/44—Palladium
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
    • C07C255/34—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring with cyano groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by unsaturated carbon chains
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Materials Engineering (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Saccharide Compounds (AREA)
  • Catalysts (AREA)
PL13191850T 2012-11-08 2013-11-07 Sposób syntezy (2E)-3-(3,4-dimetoksyfenylo)prop-2-enonitrylu i jego zastosowanie w syntezie iwabradyny i jej soli addycyjnych z dopuszczalnym farmaceutycznie kwasem PL2730562T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1260576A FR2997696B1 (fr) 2012-11-08 2012-11-08 Nouveau procede de synthese du (2e)-3-(3,4-dimethoxyphenyl)prop-2-enenitrile, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
EP13191850.0A EP2730562B1 (fr) 2012-11-08 2013-11-07 Nouveau procédé de synthèse du (2E)-3-(3,4-dimethoxyphényl)prop-2-enenitrile, et application à la synthèse de l'ivabradine et de ses sels d'addition à un acide pharmaceutiquement acceptable

Publications (1)

Publication Number Publication Date
PL2730562T3 true PL2730562T3 (pl) 2015-08-31

Family

ID=47598957

Family Applications (1)

Application Number Title Priority Date Filing Date
PL13191850T PL2730562T3 (pl) 2012-11-08 2013-11-07 Sposób syntezy (2E)-3-(3,4-dimetoksyfenylo)prop-2-enonitrylu i jego zastosowanie w syntezie iwabradyny i jej soli addycyjnych z dopuszczalnym farmaceutycznie kwasem

Country Status (35)

Country Link
US (1) US8779122B2 (pl)
EP (1) EP2730562B1 (pl)
JP (2) JP6058519B2 (pl)
KR (1) KR20140059731A (pl)
CN (1) CN103804225B (pl)
AR (1) AR093373A1 (pl)
AU (1) AU2013245452C1 (pl)
BR (1) BR102013028259A2 (pl)
CA (1) CA2831289C (pl)
CY (1) CY1116253T1 (pl)
DK (1) DK2730562T3 (pl)
EA (1) EA027080B1 (pl)
ES (1) ES2539618T3 (pl)
FR (1) FR2997696B1 (pl)
GE (1) GEP20156308B (pl)
HR (1) HRP20150570T1 (pl)
HU (1) HUE026525T2 (pl)
JO (1) JO3189B1 (pl)
MA (1) MA35147B1 (pl)
MD (1) MD4392C1 (pl)
ME (1) ME02120B (pl)
MX (1) MX355590B (pl)
MY (1) MY159701A (pl)
NZ (1) NZ616768A (pl)
PL (1) PL2730562T3 (pl)
PT (1) PT2730562E (pl)
RS (1) RS53993B1 (pl)
SA (1) SA113350005B1 (pl)
SG (1) SG2013077235A (pl)
SI (1) SI2730562T1 (pl)
TW (1) TWI488833B (pl)
UA (1) UA118008C2 (pl)
UY (1) UY35108A (pl)
WO (1) WO2014072640A1 (pl)
ZA (1) ZA201308001B (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3101010A1 (en) 2015-06-03 2016-12-07 Urquima S.A. New method for the preparation of highly pure ivabradine base and salts thereof
CN105541605A (zh) * 2016-02-04 2016-05-04 扬州大学 一种轴手性联萘配体前体(s)-2,2’-二羧酸-1,1’-联萘的合成方法
JP7248578B2 (ja) 2017-08-31 2023-03-29 第一三共株式会社 抗体－薬物コンジュゲートの新規製造方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5310598B2 (pl) * 1972-01-28 1978-04-14
JPH0753692B2 (ja) * 1990-10-30 1995-06-07 工業技術院長 芳香族カルボン酸エステル類の製造方法
FR2681862B1 (fr) * 1991-09-27 1993-11-12 Adir Cie Nouvelles (benzocycloalkyl)alkylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent.
DE4333711A1 (de) * 1993-10-02 1995-04-06 Hoechst Ag 2,4,5-Trihalogenzimtsäurenitrile und Verfahren zu ihrer Herstellung
DE10159270A1 (de) * 2001-12-03 2003-06-12 Bayer Ag Verfahren zur Arylierung von Olefinen
WO2005123662A1 (en) * 2004-06-18 2005-12-29 Janssen Pharmaceutica N.V. Modified heck reaction
CN101407474B (zh) * 2008-11-18 2011-12-14 东华大学 一种2-溴-4,5-二甲氧基苯丙腈的制备方法
WO2011138825A1 (ja) 2010-05-06 2011-11-10 株式会社島津製作所 材料試験機
HUP1000245A2 (en) * 2010-05-07 2011-11-28 Richter Gedeon Nyrt Industrial process for the production ivabradin salts
CN102464595B (zh) * 2010-11-17 2015-02-25 山东新时代药业有限公司 一种伊伐布雷定中间体的合成方法

Also Published As

Publication number Publication date
HRP20150570T1 (en) 2015-07-03
CA2831289C (en) 2016-02-09
MD4392B1 (ro) 2016-01-31
JP2016047837A (ja) 2016-04-07
AR093373A1 (es) 2015-06-03
EA027080B1 (ru) 2017-06-30
EA201301136A2 (ru) 2014-05-30
NZ616768A (en) 2015-02-27
JO3189B1 (ar) 2018-03-08
MD4392C1 (ro) 2016-08-31
MX355590B (es) 2018-04-24
HUE026525T2 (en) 2016-06-28
WO2014072640A1 (fr) 2014-05-15
ME02120B (me) 2015-10-20
BR102013028259A2 (pt) 2014-10-07
UY35108A (es) 2014-05-30
PT2730562E (pt) 2015-05-20
EP2730562B1 (fr) 2015-03-25
EA201301136A3 (ru) 2014-07-30
EP2730562A1 (fr) 2014-05-14
HK1198159A1 (zh) 2015-03-13
RS53993B1 (sr) 2015-10-30
MD20130082A2 (en) 2014-05-31
CN103804225B (zh) 2016-02-17
ZA201308001B (en) 2014-07-30
MY159701A (en) 2017-01-13
AU2013245452B2 (en) 2017-02-16
CA2831289A1 (en) 2014-05-08
FR2997696B1 (fr) 2014-12-05
TW201418197A (zh) 2014-05-16
CN103804225A (zh) 2014-05-21
JP6058519B2 (ja) 2017-01-11
ES2539618T3 (es) 2015-07-02
MX2013012858A (es) 2014-08-07
US8779122B2 (en) 2014-07-15
UA118008C2 (uk) 2018-11-12
SG2013077235A (en) 2014-06-27
DK2730562T3 (en) 2015-06-29
GEP20156308B (en) 2015-06-25
KR20140059731A (ko) 2014-05-16
SA113350005B1 (ar) 2015-12-06
US20140128598A1 (en) 2014-05-08
FR2997696A1 (fr) 2014-05-09
AU2013245452C1 (en) 2017-06-22
MA35147B1 (fr) 2014-06-02
TWI488833B (zh) 2015-06-21
AU2013245452A1 (en) 2014-05-22
JP2014114275A (ja) 2014-06-26
HK1193408A1 (en) 2014-09-19
CY1116253T1 (el) 2017-02-08
SI2730562T1 (sl) 2015-07-31

Similar Documents

Publication Publication Date Title
NO2022043I1 (en) Asciminib or a pharmaceutically acceptable salt thereof, such as asciminib hydrochloride
IL236494A0 (en) 4-methyl-9,9,5,3,2b-pentaza-cyclopenta[a]naphthalenes
ZA201404881B (en) Process for the manufacture of 1-[2-(2,4-dimethyl-phenylsulfanyl)-phenyl]-piperazine
EP2611762A4 (en) 1,3,3,3-TETRAFLUORPROPENE PROCESSAZEOTROPE WITH HF
EP2562152A4 (en) PROCESS FOR PREPARING 2,5-DIMETHYLPHENYL-ACETIC ACID
IL233926A0 (en) A method for producing derivatives of 5,3-bis(fluoroalkyl)-pyrazole-4-carboxylic acid and 5,3-bis(fluoroalkyl)-pyrazoles
EP2687519A4 (en) PROCESS FOR PRODUCING 1,2-BENZISOTHIAZOL-3-ONE COMPOUNDS
EP2687520A4 (en) PROCESS FOR PREPARING A 1,2-BENZISOTHIAZOL-3-ON COMPOUND
SG11201509227PA (en) Chemical-mechanical polishing compositions comprising n,n,n',n'-tetrakis-(2-hydroxypropyl)-ethylenediamine or methanesulfonic acid
HRP20150570T1 (en) Novel method for synthesising (2e)-3-(3,4-dimethoxyphenyl)prop-2-enenitrile and use for synthesising ivabradine and the added salts thereof with a pharmaceutically acceptable acid
SI2487158T1 (sl) Nov postopek sinteze ivabradina in njegovih dodatnh soli s farmacevstsko sprejemljivo kislino
ZA201303652B (en) Diode, use thereof, and a method for producing the same
SI2607353T1 (sl) Nov postopek sintetize ivabradina in njegovih dodatnih soli s farmacevtsko sprejemljivo kislino
SI2803659T1 (sl) Postopek za sintetiziranje 3,4-dimetoksibiciklo(4.2.0)okta-1,3,5-trien-7-karbonitrila ter uporaba za sintetiziranje ivabradina in njegovih dodatnih soli s farmacevtsko sprejemljivo kislino
PL393268A1 (pl) Kwas 2-amino-6-dihydroksyborylo-1,2,3,4-tetrahydronaftaleno-2-karboksylowy i sposób jego wytwarzania
ZA201309038B (en) New process for the synthesis of 3-(2-bromo-4,5-dimethoxyphenyl)propanenitrile, and application in the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
PL2719689T3 (pl) Nowy sposób syntezy (3-(2-bromo-4,5-dimetoksyfenylo)propanonitrylu i zastosowanie do syntezy iwabradyny i jej soli addycyjnych z farmaceutycznie dopuszczalnym kwasem
PL391832A1 (pl) Sole N-triazynyloamoniowe, sposób ich wytwarzania oraz ich zastosowanie
PL393501A1 (pl) Nowe sole jodoniowe, sposób ich wytwarzania i zastosowanie oraz nowy związek wyjściowy do wytwarzania nowych soli jodoniowych, sposób jego wytwarzania i zastosowanie
PL392177A1 (pl) Nowy aldehyd S-(+)-(5,5-dimetylocykloheks-2-en-1-ylo)octowy i sposób jego otrzymywania
PL392178A1 (pl) Nowy aldehyd R-(-)-(5,5-dimetylocykloheks-2-en-1-ylo)octowy i sposób jego otrzymywania
ME03428B (me) Postupak za proizvodnju 1-[2-(2,4-dimetil-fenilsulfanil)-fenil]-piperazina
PL392174A1 (pl) Nowe octany 2-(5,5-dimetylocykloheks-2-en-1-ylo)etylu i sposób ich otrzymywania